Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Haas, Jürgen [VerfasserIn]   i
 Würthwein, Cornelia [VerfasserIn]   i
 Korporal-Kuhnke, Mirjam [VerfasserIn]   i
 Viehöver, Andrea Maria [VerfasserIn]   i
 Jarius, Sven [VerfasserIn]   i
 Wildemann, Brigitte [VerfasserIn]   i
Titel:Alemtuzumab in Multiple Sclerosis
Titelzusatz:short- and long-term effects of immunodepletion on the peripheral treg compartment
Verf.angabe:Jürgen Haas, Cornelia Würthwein, Mirjam Korporal-Kuhnke, Andrea Viehoever, Sven Jarius, Tobias Ruck, Steffen Pfeuffer, Sven G. Meuth and Brigitte Wildemann
E-Jahr:2019
Jahr:04 June 2019
Umfang:11 S.
Fussnoten:Gesehen am 16.08.2019
Titel Quelle:Enthalten in: Frontiers in immunology
Ort Quelle:Lausanne : Frontiers Media, 2010
Jahr Quelle:2019
Band/Heft Quelle:10(2019) Artikel-Nummer 1204, 11 Seiten
ISSN Quelle:1664-3224
Abstract:Treatment with alemtuzumab is followed by an early increase in Treg frequencies. Whether naïve and memory subsets are differentially affected and how depletion influences dysfunctional MS-Treg is unclear. In this study, we analyzed the effect of alemtuzumab on regulatory T-cells (Treg) in patients with multiple sclerosis (MS). For this purpose 182 blood samples from 25 MS patients were taken shortly before treatment and serially for up to 24 months after two alemtuzumab cycles. We studied Treg by flow cytometry (quantitation, phenotypical characterization), real-time polymerase chain reaction (TCR excision circles [TREC] content), CDR3-spectratyping (clonal distribution), and proliferation assays (suppressive function). CD52-mediated cytolysis of Treg and conventional T-cells was determined by a complement-dependent cytolysis assay. Our studies revealed that one week post-alemtuzumab, Treg were depicted at constant frequencies among CD4+ T-cells. In contrast, Treg frequencies were massively increased at month 1. Post-depletional Treg exhibited a CD45RO+ memory phenotype, a skewed TCR repertoire, and contained minimum TREC numbers. Naïve Treg, thymic markers, and TCR-variability commenced to rise after 6 months but did not attain baseline levels. In vitro, Treg exhibited higher susceptibility to lysis than Tcon. Treg suppressive function constantly increased within 1 year when co-cultured with syngeneic T-cells, but remained stable against allogeneic T-cells from normal donors. Our findings suggest that (1) Treg are not spared from alemtuzumab-mediated depletion and thymopoiesis does not considerably contribute to long-term recovery, (2) either homeostatic proliferation and/or conversion from residual Tcon contributes to Treg expansion during the early post-treatment phase (3) the enhanced inhibitory effect of Treg following alemtuzumab is due to altered composition and reactivity of post-depletional Tcon.
DOI:doi:10.3389/fimmu.2019.01204
URL:Volltext ; Verlag: https://doi.org/10.3389/fimmu.2019.01204
 Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2019.01204/full
 DOI: https://doi.org/10.3389/fimmu.2019.01204
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1671531590
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68421474   QR-Code
zum Seitenanfang